GLP-1 Agonists for Diabetes: Mounjaro Versus Ozempic
XTalks
NOVEMBER 9, 2022
GLP-1 receptor agonists, or incretin (metabolic hormones) mimetics, are analogs of the GLP-1 peptide hormone that binds to the GLP-1 receptor to regulate blood sugar levels by boosting insulin secretion. dependent insulin secretion and suppression of glucagon release. billion in 2021 to $61.6 billion by 2030.
Let's personalize your content